In the BioHarmony Drug Report Database

"Preview" Icon

Vinblastine

Velban (vinblastine) is a small molecule pharmaceutical. Vinblastine was first approved as Velban on 1982-01-01. It is used to treat breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, and hodgkin disease amongst others in the USA. The pharmaceutical is active against tubulin beta chain.

 

Trade Name

 

Velban
 

Common Name

 

vinblastine
 

ChEMBL ID

 

CHEMBL159
 

Indication

 

breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, hodgkin disease, kaposi sarcoma, kidney neoplasms, lung neoplasms, mycosis fungoides, testicular neoplasms, thrombocytopenic purpura idiopathic
 

Drug Class

 

Antihistaminics (histamine-H1 receptor antagonists); vinca alkaloids

Image (chem structure or protein)

Vinblastine structure rendering